Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ELAD®
DEVICE
2 trials
Sponsors
Vital Therapies, Inc.
Conditions
Fulminant Hepatic Failure
Liver Failure
Phase 2
Safety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failure (FHF)
Withdrawn
NCT00832728
Vital Therapies, Inc.
Fulminant Hepatic Failure
Start: 2009-03-31
End: 2011-09-30
Updated: 2012-07-25
Unknown Phase
Use of the ELAD® in Patients With Liver Failure to Provide Expanded Access With Cost Recovery
NCT00832273
Vital Therapies, Inc.
Liver Failure
Updated: 2013-09-10